Several studies have shown that anti-VEGF drugs combined with PRP therapy have a certain benefit in vision improvement compared with monotherapy, and are superior to laser photocoagulation alone in vision improvement for CI-DME (center-involving diabetic macular edema); this makes them suitable for becoming the first-line DME treatment [106,107,108,109]. Here, VEGFA is linked to diabetic macular edema.